The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients
BackgroundLimited data are available on factors that affect warfarin dose requirement in Saudi patients. Saudis are among the underrepresented ethnic groups in warfarin pharmacogenetics research. The present study investigated the frequency of CYP2C9*2 and*3, CYP4F2 (G1347A) and VKORC1 –1639G>...
Saved in:
| Main Authors: | Salha Jokhab, Maha M. AlRasheed, Dana Bakheet, Abdulkareem AlMomen, Nouf AlAboud, Farhad Kamali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1547142/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment of Acenocoumarol Pharmacogenetic Algorithm Including CYP2C9 and VKORC1 Genotypes in Bulgarian Patients Treated with Coumarin Anticoagulants
by: Tzveova R., et al.
Published: (2025-06-01) -
Efficacy and safety of warfarin therapy in patients with atrial fibrillation using genotype-guided dosing method
by: M. Yu. Kolesnyk, et al.
Published: (2022-09-01) -
The influence of clinical and genetic factors on the stability of warfarin’s anticoagulant effect in patients with atrial fibrillation
by: Ya. M. Mykhailovskyi
Published: (2022-06-01) -
Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms
by: Yu. P. Skirdenko, et al.
Published: (2016-11-01) -
POLYMORPHISMS OF THE CYP1A1, CYP1A2, CYP19, AND SULT1A1 GENES ARE NOT ASSOCIATED WITH INFERTILITY IN WOMEN WITH GENITAL ENDOMETRIOSIS
by: LARISA N. Danilova, et al.
Published: (2018-09-01)